La Crosse virus is a mosquito-borne bunyavirus that has been neglected as a cause of pediatric central nervous system (CNS) infection. The disease recurs every summer in endemic foci in the midwestern and mid-Atlantic United States in areas forested with hardwood trees, which provide breeding sites for the treehole-dwelling mosquito vector, Aedes triseriatus.1 During hyperendemic years, the prevalence of disease in some of these areas can be remarkably high, exceeding that of bacterial meningitis.1 2 Clinical manifestations in symptomatic cases of La Crosse encephalitis (LE) tend to cluster into a mild form or a severe form of the disease.3-10 The usual clinical course (80% to 90%) is the mild form in which headache, fever, and vomiting frequently occur on days 1 to 3. Lethargy, behavioral changes, and/or brief seizures may occur on days 3 and 4, followed by improvement over a 7- to 8-day period. The...
Skip Nav Destination
Article navigation
1 February 1997
Experience and Reason|
February 01 1997
Treatment of Severe La Crosse Encephalitis With Intravenous Ribavirin Following Diagnosis by Brain Biopsy
Address correspondence to: James E. McJunkin, MD, Robert C. Byrd Health Sciences Center, 830 Pennsylvania Avenue, Suite 104, Charleston, WV 25302–3389.
Pediatrics (1997) 99 (2): 261–267.
Article history
Received:
December 04 1995
Accepted:
April 10 1996
Citation
James E. McJunkin, Raheel Khan, Emily C. de los Reyes, Debra L. Parsons, Linda L. Minnich, Rebecca G. Ashley, Theodore F. Tsai; Treatment of Severe La Crosse Encephalitis With Intravenous Ribavirin Following Diagnosis by Brain Biopsy. Pediatrics February 1997; 99 (2): 261–267. 10.1542/peds.99.2.261
Download citation file:
0 Comments
Comments Icon
Comments (0)
Sign in
Don't already have an account? Register
Pay-Per-View Access
$25.00